Masutani Satoshi, Senzaki Hideaki, Ishido Hirotaka, Taketazu Mio, Matsunaga Tamotsu, Kobayashi Toshiki, Sasaki Nozomu, Asano Haruhiko, Kyo Shunei, Yokote Yuji
Department of Pediatric Cardiology and Cardiovascular Surgery, Saitama Heart Institute, Saitama Medical School Hospital, Saitama, Japan.
Pediatr Int. 2005 Apr;47(2):132-6. doi: 10.1111/j.1442-200x.2005.02043.x.
Many recent studies suggest that vasopressin deficiency is an important cause of catecholamine-resistant hypotension with vasodilation in adults, but little is known about vasopressin deficiency in children.
To clarify the usefulness of vasopressin administration in pediatric cathecolamine-resistant hypotension with preserved ventricular contractility, urinary output and blood pressure response to vasopressin were retrospectively analyzed in 12 consecutive patients (15 instances) who were treated with vasopressin. The causes of vasodilation were central nervous system disturbance (n = 5), side-effect of drug (n = 5), and infection (n = 5). Plasma vasopressin concentration was measured six times before vasopressin administration and five times during vasopressin administration.
Patients were divided into four groups according to their response to vasopressin administration. In group 1 (n = 5), urinary output increased to > 3 mL/kg per h within 3 h after vasopressin administration. In group 2 (n = 4), urinary output increased to > 3 mL/kg per h from 3 to 5 h after vasopressin administration. In group 3 (n = 4), urinary output did not increase to > 3 mL/kg per min within 5 h after vasopressin administration, but systolic blood pressure increased to > 120% of the level at the time of vasopressin administration. All remaining patients were classified into group 4 (n = 3). Plasma vasopressin concentration were low considering the markedly hypotensive state in all six instances. Plasma vasopressin concentration during vasopressin administration were significantly increased compared with before administration (P < 0.05). No apparent side-effects were observed in this series.
Vasopressin deficiency may occur in catecholamine-resistant hypotension of pediatric patients due to various causes including central nervous system disturbance, drug induced hypotension and sepsis. Small doses of vasopressin administration seems to be very effective in such conditions by increasing blood pressure and urinary output.
许多近期研究表明,血管加压素缺乏是成人中儿茶酚胺抵抗性低血压伴血管舒张的重要原因,但关于儿童血管加压素缺乏的情况知之甚少。
为阐明血管加压素给药在具有保留心室收缩力的小儿儿茶酚胺抵抗性低血压中的作用,对连续12例接受血管加压素治疗的患者(15例次)的尿量及血压对血管加压素的反应进行了回顾性分析。血管舒张的原因包括中枢神经系统紊乱(n = 5)、药物副作用(n = 5)和感染(n = 5)。在血管加压素给药前测量血浆血管加压素浓度6次,给药期间测量5次。
根据患者对血管加压素给药的反应分为四组。第1组(n = 5),血管加压素给药后3小时内尿量增加至>3 mL/(kg·h)。第2组(n = 4),血管加压素给药后3至5小时尿量增加至>3 mL/(kg·h)。第3组(n = 4),血管加压素给药后5小时内尿量未增加至>3 mL/(kg·min),但收缩压升高至血管加压素给药时水平的>120%。其余所有患者归为第4组(n = 3)。考虑到所有6例次均处于明显低血压状态,血浆血管加压素浓度较低。血管加压素给药期间的血浆血管加压素浓度与给药前相比显著升高(P < 0.05)。本系列中未观察到明显副作用。
小儿患者因各种原因(包括中枢神经系统紊乱、药物性低血压和脓毒症)导致的儿茶酚胺抵抗性低血压中可能发生血管加压素缺乏。小剂量血管加压素给药在此类情况下通过升高血压和尿量似乎非常有效。